JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
| $2.53M | ﹤0.01% |
194,503
-312,369
| -62% | -$4.21M |
|
3827
CALL
Zscaler
ZS
$29.7B
| $2.53M | ﹤0.01% |
14,000
+1,500
| +12% | +$290K |
|
|
AUTL
3828
Autolus Therapeutics
AUTL
$572M
| $2.52M | ﹤0.01% |
1,071,533
-213,175
| -17% | -$721K |
|
3829
Myers Industries
MYE
$1.24B
| $2.51M | ﹤0.01% |
227,635
+94,129
| +71% | +$1.13M |
|
3830
PUT
DraftKings
DKNG
$13B
| $2.51M | ﹤0.01% |
67,500
+17,500
| +35% | +$694K |
|
3831
Fidelity Fundamental Large Cap Growth ETF
FFLG
$624M
| $2.51M | ﹤0.01% |
100,110
-4,525
| -4% | -$113K |
|
3832
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.14B
| $2.51M | ﹤0.01% |
21,573
-9,687
| -31% | -$1.18M |
|
|
BEAGU
3833
Bold Eagle Acquisition Corp Units
BEAGU
| $2.51M | ﹤0.01% |
+248,906
| New | +$2.5M |
|
3834
MetroCity Bankshares
MCBS
$1.04B
| $2.5M | ﹤0.01% |
78,276
+35,118
| +81% | +$1.14M |
|
3835
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $2.5M | ﹤0.01% |
74,889
-8,193
| -10% | -$283K |
|
3836
Oaktree Specialty Lending
OCSL
$1.14B
| $2.5M | ﹤0.01% |
163,387
+82,464
| +102% | +$1.32M |
|
3837
Titan Machinery
TITN
$429M
| $2.5M | ﹤0.01% |
176,652
+3,626
| +2% | +$52.5K |
|
3838
Summit Therapeutics
SMMT
$10.6B
| $2.49M | ﹤0.01% |
139,581
-23,068
| -14% | -$447K |
|
|
RGEF
3839
Rockefeller Global Equity ETF
RGEF
$839M
| $2.48M | ﹤0.01% |
+100,409
| New | +$2.52M |
|
3840
PUT
PENN Entertainment
PENN
$2.52B
| $2.48M | ﹤0.01% |
125,000
+116,300
| +1,337% | +$2.29M |
|
3841
Bar Harbor Bankshares
BHB
$681M
| $2.48M | ﹤0.01% |
81,000
+30,084
| +59% | +$995K |
|
3842
Invesco Water Resources ETF
PHO
$2.05B
| $2.47M | ﹤0.01% |
37,583
-12,651
| -25% | -$882K |
|
3843
PUT
Remitly
RELY
$5.54B
| $2.46M | ﹤0.01% |
+109,200
| New | +$2.01M |
|
|
MTLS
3844
Materialise
MTLS
$400M
| $2.46M | ﹤0.01% |
349,346
+308,108
| +747% | +$2.04M |
|
3845
CALL
Vaxcyte
PCVX
$8.64B
| $2.46M | ﹤0.01% |
30,000
| – | – |
|
|
3846
PUT
Vaxcyte
PCVX
$8.64B
| $2.46M | ﹤0.01% |
30,000
-13,000
| -30% | -$1.29M |
|
3847
CALL
Scorpio Tankers
STNG
$3.98B
| $2.45M | ﹤0.01% |
+49,400
| New | +$2.82M |
|
3848
iShares S&P 500 BuyWrite ETF
IVVW
$341M
| $2.45M | ﹤0.01% |
50,000
| – | – |
|
3849
PUT
Enovix
ENVX
$963M
| $2.45M | ﹤0.01% |
257,371
| – | – |
|
3850
Global X MSCI Argentina ETF
ARGT
$808M
| $2.45M | ﹤0.01% |
29,581
+10,067
| +52% | +$781K |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.